Yahoo Web Search

Search results

1. • 

     Ozempic, Wegovy May Protect Kidney Health, New Research Finds

     Health via Yahoo News· 3 days ago

     Ozempic and Wegovy may be able to significantly reduce the risk of kidney complications, heart...

2. • 

     DaVita (DVA) Gains 36% YTD: What's Driving the Stock Rally?

     Zacks via Yahoo Finance· 16 hours ago

     Value-based arrangements are proliferating in the kidney health space. These arrangements allow for...

3. • 

     3 PEG-Based Value Picks to Boost Your Portfolio Returns

     Zacks via Yahoo Finance· 15 hours ago

     DaVita: Denver, CO-headquartered DaVita is a leading provider of dialysis services in the United...

4. • ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and...

     Benzinga· 4 days ago

     WINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. PROK ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic & ...

5. • Another potential indication for Mounjaro, Zepbound

     Becker’s Hospital Review· 3 days ago

     The trial results could precede another indication for the popular drugs. Mounjaro, a Type 2 diabetes medication, and Zepbound, a weight loss injection, are part of a booming class of drugs ...

6. • ProKidney (NASDAQ:PROK) Given New $6.00 Price Target at Jefferies Financial Group

     ETF DAILY NEWS· 3 days ago

     ProKidney (NASDAQ:PROK – Free Report) had its target price reduced by Jefferies Financial Group from $15.00 to $6.00 in a research note released on Monday, Benzinga reports. Jefferies Financial ...

7. • Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...

     Morningstar· 6 days ago

     The efficacy estimandi showed 51.8%, 62.8% and 73.3% of participants taking 5 mg, 10 mg and 15 mg, respectively, achieved an absence of MASH with no worsening of fibrosis ...

8. • 

     FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D

     Zacks via Yahoo Finance· 13 hours ago

     Following the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...

9. • 

     Significant Benefit With Liver Transplantation in ACLF

     Medscape· 22 hours ago

     Liver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...

10. • 

      Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

      Zacks via Yahoo Finance· 7 days ago

      Ecolab’s shares have risen 18.7% year to date against the industry’s 20.1% decline. Ecolab has a...